Alcon spin-off prompts Novartis downgrade by Moody’s

07:55 EDT 3 Jul 2018 | PMLIVE

Selling off Alcon concentrates business in riskier areas

Original Article: Alcon spin-off prompts Novartis downgrade by Moody’s

More From BioPortfolio on "Alcon spin-off prompts Novartis downgrade by Moody’s"